Espervita Therapeutics, a biotechnology company developing targeted metabolic reprogramming therapies, announced the publication in Nature featuring groundbreaking preclinical data for the treatment ...

SkyQuest Technology Consulting published a report, titled, Remote Patient Monitoring Market - Global Opportunity Analysis and Indust ...

Ketamine’s rapid antidepressant effects may involve the brain’s opioid system, offering insight into how it works and paving ...

50% compression of full target–disease–drug analysis workflows Rare disease landscape mapping shortened from 12 weeks to under 3 ...

COVID-19 can trigger serious brain and nerve problems, including stroke, seizures, and memory loss, even weeks after recovery ...

Exposure to PFAS chemicals may raise your risk of type 2 diabetes by disrupting metabolism and how your body controls blood ...

A swallowable pill changes color to detect gut inflammation. This biosensor offers a non-invasive way to monitor IBD. It promises easier at-home care without the need for tests.

Live brain tissue study overturns decades of neuroscience beliefs—80% of genes behave differently than assumed, reshaping ...

Long COVID affects lean and obese individuals differently, causing lasting metabolic and physiological changes—even after mild infection-in a primate model ...

Disclaimer - All information and content on this site are provided for informational and educational purposes only. They should NOT be used for the diagnosis or treatment of any health-related ...

Issued on behalf of Oncolytics Biotech Inc. VANCOUVER, B.C., July 29, 2025 /PRNewswire/ -- Equity InsiderNews Commentary – The average age of cancer patients is getting younger, as experts are ...